Enzo Biochem, Inc.
ENZ was delisted on the 17th of April, 2025.
76 hedge funds and large institutions have $73M invested in Enzo Biochem, Inc. in 2020 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 22 increasing their positions, 27 reducing their positions, and 11 closing their positions.
285% more call options, than puts
Call options by funds: $277K | Put options by funds: $72K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
6% less funds holding
Funds holding: 81 → 76 (-5)
7.1% less ownership
Funds ownership: 67.77% → 60.67% (-7.1%)
14% less capital invested
Capital invested by funds: $84.8M → $73M (-$11.8M)
19% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 27
27% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$245K |
| 2 |
Millennium Management
New York
|
+$220K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$113K |
| 4 |
JP Morgan Chase
New York
|
+$96.6K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$82.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.64M |
| 2 |
FM
Fondren Management
Houston,
Texas
|
-$1.91M |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$505K |
| 4 |
Morgan Stanley
New York
|
-$330K |
| 5 |
Two Sigma Investments
New York
|
-$306K |
ENZ Hedge Fund Activity: Q1 2020 in Review
76 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q1 2020, worth a combined $73M — down 14% from $84.8M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of ENZ and 8 opened new positions — a net loss of 3 holders — while 27 trimmed existing stakes and 22 added.
The largest buyer was Vanguard Group, adding an estimated $245K. The largest seller was Wellington Management Group, cutting an estimated $4.64M.
- 76 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q1 2020, down from 81 in Q4 2019.
- Funds reported $73M of Enzo Biochem, Inc. stock for Q1 2020, down 14% quarter-over-quarter.
- 8 funds opened new Enzo Biochem, Inc. positions in Q1 2020 and 11 closed out, a net change of -3 holders.
- The largest Enzo Biochem, Inc. buyer in Q1 2020 was Vanguard Group, an estimated $245K added.
- The largest Enzo Biochem, Inc. seller in Q1 2020 was Wellington Management Group, an estimated $4.64M sold.
Based on aggregated 13F filings for Q1 2020.